Cortical abnormalities in bipolar disorder: An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group

Molecular Psychiatry

Volumn 23, Issue 4, 2018, Pages 932-942

  Hibar, D P ^a,b   Westlye, L T ^c,d   Doan, N T ^c,d   Jahanshad, N ^a   Cheung, J W ^a   Ching, C R K ^a,e   Versace, A ^f   Bilderbeck, A C ^g   Uhlmann, A ^h,i   Mwangi, B ^j   Kramer B ^k   Overs, B ^l   Hartberg, C B ^c   Abe, C ^m   Dima, D ^n,o   Grotegerd, D ^p   Sprooten, E ^q   Ben, E ^r   Jimenez, E ^s   Howells, F M ^h   Delvecchio, G ^t   Temmingh, H ^h   Starke, J ^h   Almeida, J R C ^u   Goikolea, J M ^s   Houenou, J ^v,w   Beard, L M ^x   Rauer, L ^k   Abramovic, L ^y   Bonnin, M ^s   Ponteduro, M F ^o   Keil, M ^z   Rive, M M ^aa   Yao, N ^ab,ac   Yalin, N ^o   Najt, P ^ad   Rosa, P G ^ae   Redlich, R ^p   Trost, S ^z   Hagenaars, S ^af   Fears, S C ^e,ag   Alonso Lana, S ^ah,ai   Van Erp, T G M ^aj   Nickson, T ^af   Chaim Avancini, T M ^ae   Meier, T B ^ak,al   Elvsashagen, T ^c,d   Haukvik, U K ^c   Lee, W H ^q   Schene, A H ^am,an   Lloyd, A J ^ao   Young, A H ^o   Nugent, A ^ap   Dale, A M ^aq,ar   Pfennig, A ^as   McIntosh, A M ^af   Lafer, B ^ae   Baune, B T ^at   Ekman, C J ^m   Zarate, C A ^ap   Bearden, C E ^e,au   Henry, C ^v,av   Simhandl, C ^aw   McDonald, C ^ad   Bourne, C ^g,ax   Stein, D J ^h,i   Wolf, D H ^x   Cannon, D M ^ad   Glahn, D C ^ab,ac   Veltman, D J ^ay   Pomarol Clotet, E ^ah,ai   Vieta, E ^s   Canales Rodriguez, E J ^ah,ai   Nery, F G ^ae,az   Duran, F L S ^ae   Busatto, G F ^ae   Roberts, G ^ba   Pearlson, G D ^ab,ac   Goodwin, G M ^g   Kugel, H ^p   Whalley, H C ^af   Ruhe, H G ^g,aa,bb   Soares, J C ^j   Fullerton, J M ^l,ba   Rybakowski, J K ^bc   Savitz, J ^al,bd   Chaim, K T ^ae   Fatjo Vilas M ^ah,ai   Soeiro De Souza, M G ^ae   Boks, M P ^y   Zanetti, M V ^ae   Otaduy, M C G ^ae   Schaufelberger, M S ^ae   Alda, M ^be   Ingvar, M ^m,bf   Phillips, M L ^f   Kempton, M J ^o   Bauer, M ^as   Landen M ^m,bg   Lawrence, N S ^bh   Van Haren, N E M ^y   Horn, N R ^h   Freimer, N B ^au   Gruber, O ^k   Schofield, P R ^l,ba   Mitchell, P B ^ba   Kahn, R S ^y   Lenroot, R ^l,ba   Machado Vieira, R ^ae,ap   Ophoff, R A ^y,au   Sarro S ^ah,ai   Frangou, S ^q   Satterthwaite, T D ^x   Hajek, T ^be,bi   Dannlowski, U ^p   Malt, U F ^c,d   Arolt, V ^p   Gattaz, W F ^ae   Drevets, W C ^bj   Caseras, X ^bk   Agartz, I ^c,r   Thompson, P M ^a   Andreassen, O A ^c,d   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h UNIVERSITY OF CAPE TOWN   (South Africa)

ⁱ UNIVERSITY OF CAPE TOWN   (South Africa)

^j UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF HEIDELBERG   (Germany)

^l NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ CITY UNIVERSITY   (United Kingdom)

^o KING'S COLLEGE LONDON   (United Kingdom)

^p UNIVERSITY OF MÜNSTER   (Germany)

^q MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^r DIAKONHJEMMET HOSPITAL   (Norway)

^s UNIVERSITY OF BARCELONA   (Spain)

^t IRCCS E Medea Scientific Institute ^*  (Italy)

^u BROWN UNIVERSITY   (United States)

^v HENRI MONDOR HOSPITAL   (France)

^w CEA SACLAY   (France)

^x UNIVERSITY OF PENNSYLVANIA   (United States)

^y UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^z UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^aa UNIVERSITY OF AMSTERDAM   (Netherlands)

^ab YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ac HARTFORD HOSPITAL   (United States)

^ad NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^ae UNIVERSITY OF SÃO PAULO   (Brazil)

^af UNIVERSITY OF EDINBURGH   (United Kingdom)

^ag VETERANS AFFAIRS MEDICAL CENTER   (United States)

^ah FIDMAG GERMANES HOSPITALÀRIES RESEARCH FOUNDATION   (Spain)

^ai CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^aj UNIVERSITY OF CALIFORNIA   (United States)

^ak MEDICAL COLLEGE OF WISCONSIN   (United States)

^al LAUREATE INSTITUTE FOR BRAIN RESEARCH   (United States)

^am RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^an RADBOUD UNIVERSITY   (Netherlands)

^ao NEWCASTLE UNIVERSITY   (United Kingdom)

^ap NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^aq UNIVERSITY OF CALIFORNIA   (United States)

^ar UNIVERSITY OF CALIFORNIA   (United States)

^as UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^at UNIVERSITY OF ADELAIDE   (Australia)

^au UNIVERSITY OF CALIFORNIA   (United States)

^av INSTITUT PASTEUR   (France)

^aw BIPOLAR Zentrum Wiener Neustadt   (Austria)

^ax NEWMAN UNIVERSITY   (United Kingdom)

^ay VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^az UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^ba UNIVERSITY OF NEW SOUTH WALES   (Australia)

^bb UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^bc POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^bd UNIVERSITY OF TULSA   (United States)

^be DALHOUSIE UNIVERSITY   (Canada)

^bf KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^bg UNIVERSITY OF GOTHENBURG   (Sweden)

^bh UNIVERSITY OF EXETER   (United Kingdom)

^bi NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^bj JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^bk CARDIFF UNIVERSITY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR II DISORDER; BRAIN REGION; COMORBIDITY; CONFOUNDING VARIABLE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DISEASE DURATION; FEMALE; FRONTAL LOBE; FUSIFORM GYRUS; GRAY MATTER; HEMISPHERE; HUMAN; IMAGE ANALYSIS; INFERIOR TEMPORAL GYRUS; MAJOR CLINICAL STUDY; MALE; MEDIAL FRONTAL CORTEX; MIDDLE TEMPORAL GYRUS; MOOD DISORDER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PARS OPERCULARIS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; SEX DIFFERENCE; SURFACE AREA; TEMPORAL GYRUS; TEMPORAL LOBE; YOUNG ADULT; ADOLESCENT; AGE; BRAIN; BRAIN CORTEX; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; SEX FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; BIPOLAR DISORDER; BRAIN; CASE-CONTROL STUDIES; CEREBRAL CORTEX; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROIMAGING; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; SEX FACTORS; TEMPORAL LOBE; YOUNG ADULT;

EID: 85044307410     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2017.73     Document Type: Article

References (76)

1. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011; 68: 241-251.
2. Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet 2016; 387: 1561-1572.
3. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003; 60: 497-502.
4. Wray NR, Gottesman II. Using summary data from the danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder. Front Genet 2012; 3: 118.
5. Calabrese JR, Rapport DJ, Kimmel SE, Shelton MD. Controlled trials in bipolar I depression: focus on switch rates and efficacy. Eur Neuropsychopharmacol 1999; 9 (Suppl 4): S109-S112.
6. Dunner DL. Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord 2003; 5: 456-463.
7. Ghaemi SN, Lenox MS, Baldessarini RJ. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry 2001; 62: 565-569.
8. McCombs JS, Ahn J, Tencer T, Shi L. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-forservices California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. J Affect Disord 2007; 97: 171-179.
9. Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW et al. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry 2009; 70: 699-705.
10. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Menji HK. Lithium-induced increase in human brain grey matter. Lancet 2000; 356: 1241-1242.
11. Lyoo IK, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL et al. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology 2010; 35: 1743-1750.
12. Hajek T, Bauer M, Simhandl C, Rybakowski J, O'Donovan C, Pfennig A et al. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response. Psychol Med 2014; 44: 507-517.
13. Abe C, Ekman CJ, Sellgren C, Petrovic P, Ingvar M, Landen M. Cortical thickness, volume and surface area in patients with bipolar disorder types I and II. J Psychiatry Neurosci 2015; 41: 150093.
14. Bowden CL. A different depression: clinical distinctions between bipolar and unipolar depression. J Affect Disord 2005; 84: 117-125.
15. Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord 1999; 52: 135-144.
16. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994; 31: 281-294.
17. Morselli PL, Elgie R, Europe G. GAMIAN-Europe/BEAM survey I-global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders. Bipolar Disord 2003; 5: 265-278.
18. Rakic P. The radial edifice of cortical architecture: from neuronal silhouettes to genetic engineering. Brain Res Rev 2007; 55: 204-219.
19. Rakic P. Specification of cerebral cortical areas. Science 1988; 241: 170-176.
20. Hartberg CB, Sundet K, Rimol LM, Haukvik UK, Lange EH, Nesvag R et al. Brain cortical thickness and surface area correlates of neurocognitive performance in patients with schizophrenia, bipolar disorder, and healthy adults. J Int Neuropsychol Soc 2011; 17: 1080-1093.
21. Padmanabhan JL, Tandon N, Haller CS, Mathew IT, Eack SM, Clementz BA et al. Correlations between brain structure and symptom dimensions of psychosis in schizophrenia, schizoaffective, and psychotic bipolar I disorders. Schizophr Bull 2015; 41: 154-162.
22. Kremen WS, Prom-Wormley E, Panizzon MS, Eyler LT, Fischl B, Neale MC et al. Genetic and environmental influences on the size of specific brain regions in midlife: the VETSA MRI study. Neuroimage 2010; 49: 1213-1223.
23. Blokland GA, de Zubicaray GI, McMahon KL, Wright MJ. Genetic and environmental influences on neuroimaging phenotypes: a meta-analytical perspective on twin imaging studies. Twin Res Hum Genet 2012; 15: 351-371.
24. Panizzon MS, Fennema-Notestine C, Eyler LT, Jernigan TL, Prom-Wormley E, Neale M et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex 2009; 19: 2728-2735.
25. Winkler AM, Kochunov P, Blangero J, Almasy L, Zilles K, Fox PT et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage 2010; 53: 1135-1146.
26. Hanford LC, Nazarov A, Hall GB, Sassi RB. Cortical thickness in bipolar disorder: a systematic review. Bipolar Disord 2016; 18: 4-18.
27. Elvsashagen T, Westlye LT, Boen E, Hol PK, Andreassen OA, Boye B et al. Bipolar II disorder is associated with thinning of prefrontal and temporal cortices involved in affect regulation. Bipolar Disord 2013; 15: 855-864.
28. Hegarty CE, Foland-Ross LC, Narr KL, Sugar CA, McGough JJ, Thompson PM et al. ADHD comorbidity can matter when assessing cortical thickness abnormalities in patients with bipolar disorder. Bipolar Disord 2012; 14: 843-855.
29. Foland-Ross LC, Thompson PM, Sugar CA, Madsen SK, Shen JK, Penfold C et al. Investigation of cortical thickness abnormalities in lithium-free adults with bipolar I disorder using cortical pattern matching. Am J Psychiatry 2011; 168: 530-539.
30. Fornito A, Malhi GS, Lagopoulos J, Ivanovski B, Wood SJ, Saling MM et al. Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder. Psychiatry Res 2008; 162: 123-132.
31. Fornito A, Yucel M, Wood SJ, Bechdolf A, Carter S, Adamson C et al. Anterior cingulate cortex abnormalities associated with a first psychotic episode in bipolar disorder. Br J Psychiatry 2009; 194: 426-433.
32. Lyoo IK, Sung YH, Dager SR, Friedman SD, Lee JY, Kim SJ et al. Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord 2006; 8: 65-74.
33. Rimol LM, Hartberg CB, Nesvag R, Fennema-Notestine C, Hagler DJ, Pung CJ et al. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry 2010; 68: 41-50.
34. Maller JJ, Thaveenthiran P, Thomson RH, McQueen S, Fitzgerald PB. Volumetric, cortical thickness and white matter integrity alterations in bipolar disorder type I and II. J Affect Disord 2014; 169: 118-127.
35. Ratnanather JT, Cebron S, Ceyhan E, Postell E, Pisano DV, Poynton CB et al. Morphometric differences in planum temporale in schizophrenia and bipolar disorder revealed by statistical analysis of labeled cortical depth maps. Front Psychiatry 2014; 5: 94.
36. Janssen J, Aleman-Gomez Y, Schnack H, Balaban E, Pina-Camacho L, Alfaro-Almagro F et al. Cortical morphology of adolescents with bipolar disorder and with schizophrenia. Schizophr Res 2014; 158: 91-99.
37. Lan MJ, Chhetry BT, Oquendo MA, Sublette ME, Sullivan G, Mann JJ et al. Cortical thickness differences between bipolar depression and major depressive disorder. Bipolar Disord 2014; 16: 378-388. Cortical abnormalities in BD DP Hibar et al 941
38. Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivieres S, Jahanshad N et al. Common genetic variants influence human subcortical brain structures. Nature 2015; 520: 224-229.
39. Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav 2014; 8: 153-182.
40. Hibar DP, Westlye LT, van Erp TG, Rasmussen J, Leonardo CD, Faskowitz J et al. Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry 2016; 21: 1710-1716.
41. Schmaal L, Hibar DP, Samann PG, Hall GB, Baune BT, Jahanshad N et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry advance online publication, 3 May 2016; doi: 10.1038/mp.2016.60.
42. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341-355.
43. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006; 31: 968-980.
44. Westlye LT, Walhovd KB, Dale AM, Bjornerud A, Due-Tonnessen P, Engvig A et al. Differentiating maturational and aging-related changes of the cerebral cortex by use of thickness and signal intensity. Neuroimage 2010; 52: 172-185.
45. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995; 57: 289-300.
46. Im K, Lee JM, Lee J, Shin YW, Kim IY, Kwon JS et al. Gender difference analysis of cortical thickness in healthy young adults with surface-based methods. Neuroimage 2006; 31: 31-38.
47. Pontious A, Kowalczyk T, Englund C, Hevner RF. Role of intermediate progenitor cells in cerebral cortex development. Dev Neurosci 2008; 30: 24-32.
48. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 1999; 72: 879-882.
49. Hilton EJ, Hosking SL, Betts T. The effect of antiepileptic drugs on visual performance. Seizure 2004; 13: 113-128.
50. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011; 68: 128-137.
51. Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev 2013; 37: 1680-1691.
52. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry 2009; 195: 194-201.
53. Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008; 65: 1017-1032.
54. Tesli M, Egeland R, Sønderby IE, Haukvik UK, Bettella F, Hibar DP et al. No evidence for association between bipolar disorder risk gene variants and brain structural phenotypes. J Affect Disord 2013; 151: 291-297.
55. Lim CS, Baldessarini RJ, Vieta E, Yucel M, Bora E, Sim K. Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev 2013; 37: 418-435.
56. Duffy A, Horrocks J, Doucette S, Keown-Stoneman C, McCloskey S, Grof P. The developmental trajectory of bipolar disorder. Br J Psychiatry 2014; 204: 122-128.
57. Bootsman F, Brouwer RM, Kemner SM, Schnack HG, van der Schot AC, Vonk R et al. Contribution of genes and unique environment to cross-sectional and longitudinal measures of subcortical volumes in bipolar disorder. Eur Neuropsychopharmacol 2015; 25: 2197-2209.
58. Abe C, Ekman CJ, Sellgren C, Petrovic P, Ingvar M, Landen M. Manic episodes are related to changes in frontal cortex: a longitudinal neuroimaging study of bipolar disorder 1. Brain 2015; 138(Pt 11): 3440-3448.
59. Liberg B, Rahm C, Panayiotou A, Pantelis C. Brain change trajectories that differentiate the major psychoses. Eur J Clin Invest 2016; 46: 658-674.
60. Jernigan TL, Butters N, Ditraglia G, Schafer K, Smith T, Riwin M et al. Reduced cerebral gray-matter observed in alcoholics using magnetic-resonance-imaging. Alcohol Clin Exp Res 1991; 15: 418-427.
61. Karama S, Ducharme S, Corley J, Chouinard-Decorte F, Starr JM, Wardlaw JM et al. Cigarette smoking and thinning of the brain's cortex. Mol Psychiatry 2015; 20: 778-785.
62. Jorgensen KN, Skjaervo I, Morch-Johnsen L, Haukvik UK, Lange EH, Melle I et al. Cigarette smoking is associated with thinner cingulate and insular cortices in patients with severe mental illness. J Psychiatry Neurosci 2015; 40: 241-249.
63. Makris N, Gasic GP, Kennedy DN, Hodge SM, Kaiser JR, Lee MJ et al. Cortical thickness abnormalities in cocaine addiction-A reflection of both drug use and a pre-existing disposition to drug abuse? Neuron 2008; 60: 174-188.
64. Sarrazin S, Poupon C, Linke J, Wessa M, Phillips M, Delavest M et al. A multicenter tractography study of deep white matter tracts in bipolar I disorder: psychotic features and interhemispheric disconnectivity. JAMA Psychiatry 2014; 71: 388-396.
65. Chai XJ, Whitfield-Gabrieli S, Shinn AK, Gabrieli JD, Nieto Castanon A, McCarthy JM et al. Abnormal medial prefrontal cortex resting-state connectivity in bipolar disorder and schizophrenia. Neuropsychopharmacology 2011; 36: 2009-2017.
66. Phillips ML, Swartz HA. A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research. Am J Psychiatry 2014; 171: 829-843.
67. Rive MM, Mocking RJ, Koeter MW, van Wingen G, de Wit SJ, van den Heuvel OA et al. State-dependent differences in emotion regulation between unmedicated bipolar disorder and major depressive disorder. JAMA Psychiatry 2015; 72: 687-696.
68. Rive MM, Koeter MW, Veltman DJ, Schene AH, Ruhe HG. Visuospatial planning in unmedicated major depressive disorder and bipolar disorder: distinct and common neural correlates. Psychol Med 2016; 46: 2313-2328.
69. Roberts G, Green MJ, Breakspear M, McCormack C, Frankland A, Wright A et al. Reduced inferior frontal gyrus activation during response inhibition to emotional stimuli in youth at high risk of bipolar disorder. Biol Psychiatry 2013; 74: 55-61.
70. Hanford LC, Sassi RB, Hall GB. Accuracy of emotion labeling in children of parents diagnosed with bipolar disorder. J Affect Disord 2016; 194: 226-233.
71. Caspers S, Zilles K, Laird AR, Eickhoff SB. ALE meta-analysis of action observation and imitation in the human brain. Neuroimage 2010; 50: 1148-1167.
72. Vigneau M, Beaucousin V, Herve PY, Duffau H, Crivello F, Houde O et al. Meta-analyzing left hemisphere language areas: phonology, semantics, and sentence processing. Neuroimage 2006; 30: 1414-1432.
73. Phillips M, Ladouceur C, Drevets W. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry 2008; 13: 833-857.
74. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 2003; 54: 515-528.
75. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010; 35: 192-216.
76. Fears SC, Service SK, Kremeyer B, Araya C, Araya X, Bejarano J et al. Multisystem component phenotypes of bipolar disorder for genetic investigations of extended pedigrees. JAMA Psychiatry 2014; 71: 375-387.